The CNS Diseases World Summit brings together experts from academia and industry to discuss cutting edge research and new technologies used in the pharmaceutical and biotech fields. The summit takes place in San Francisco, CA on September 22-23, 2011 and includes three concurrent tracks.
- Advances in Neuropsychiatric Treatment
- 5th Neurodegenerative Conditions Research and Development
- 4th CNS Partnering and Deal-making
Network with representatives from prestigious organizations and discuss the latest research from top leaders in the pharmaceutical and biotech industries including Abbott, Amgen, AstraZeneca, Biogen Idec, Boehringer Ingleheim, Bristol-Myers Squibb, Elan, EnVivo, Janssen, Johnson and Johnson, Merck, NIA, NIH, Novo Ventures, Pfizer, Quintiles, Roche, Sanofi-Aventis, Stanford University, Targacept, UCSF, and many more!
